GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starton Therapeutics Inc (NAS:STA) » Definitions » Pre-Tax Income

Starton Therapeutics (Starton Therapeutics) Pre-Tax Income : $-7.64 Mil (TTM As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Starton Therapeutics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Starton Therapeutics's pretax income for the three months ended in Jun. 2023 was $-3.05 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2023 was $-7.64 Mil. Starton Therapeutics's pretax margin was %.


Starton Therapeutics Pre-Tax Income Historical Data

The historical data trend for Starton Therapeutics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starton Therapeutics Pre-Tax Income Chart

Starton Therapeutics Annual Data
Trend Mar21 Mar22 Mar23
Pre-Tax Income
-9.21 -11.93 -9.99

Starton Therapeutics Quarterly Data
Mar21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23
Pre-Tax Income Get a 7-Day Free Trial -3.29 -2.88 -2.22 -2.38 -3.05

Competitive Comparison of Starton Therapeutics's Pre-Tax Income

For the Biotechnology subindustry, Starton Therapeutics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Starton Therapeutics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Starton Therapeutics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Starton Therapeutics's Pre-Tax Income falls into.



Starton Therapeutics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Starton Therapeutics's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-9.993+0+0+0+0
=-9.99

Starton Therapeutics's Pretax Income for the quarter that ended in Jun. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-3.049+0+0+0+0
=-3.05

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Starton Therapeutics  (NAS:STA) Pre-Tax Income Explanation

Starton Therapeutics's Pretax Margin for the quarter that ended in Jun. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-3.049/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Starton Therapeutics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Starton Therapeutics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Starton Therapeutics (Starton Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
215 College Road, Suite No.300, Paramus, NJ, USA, 07652
Starton Therapeutics Inc is a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can receive continuous treatment to live better, and longer. Starton's proprietary continuous delivery technology can increase the efficacy of approved drugs, make them more tolerable, and expand their potential use.

Starton Therapeutics (Starton Therapeutics) Headlines

No Headlines